Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1

MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer

(2017) Weijiang Zhang et al.   GENE

Identification of translationally controlled tumor protein in promotion of DNA homologous recombination repair in cancer cells by affinity proteomics

(2017) Y Li et al.   ONCOGENE

miR-125b-5p enhances chemotherapy sensitivity to cisplatin by down-regulating Bcl2 in gallbladder cancer

(2017) Dong Yang et al.   Scientific Reports

MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells

(2016) Hao Wang et al.   Cancer Cell International

miR-145 sensitizes gallbladder cancer to cisplatin by regulating multidrug resistance associated protein 1

(2016) Ming Zhan et al.   TUMOR BIOLOGY

Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas

(2016) E. Sala et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Expression profiling of O6 methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases

(2015) Xiao-Bing Jiang et al.   BMC CANCER

The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas

(2015) Zhenye Li et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer

(2015) Rui-Lei Liu et al.   TUMOR BIOLOGY

MiR-145 Expression Accelerates Esophageal Adenocarcinoma Progression by Enhancing Cell Invasion and Anoikis Resistance

(2015) Mathieu Francois Derouet et al.   PLoS One

miR-145 sensitizes ovarian cancer cells to paclitaxel by targeting Sp1 and Cdk6

(2014) Xiaolan Zhu et al.   INTERNATIONAL JOURNAL OF CANCER

miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma

(2014) Ruijing Lu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

miR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1

(2014) Enqi Li et al.   TUMOR BIOLOGY

miR-145 inhibits invasion of bladder cancer cells by targeting PAK111This study was supported by National Natural Science Foundation of China (No. 81372279 to P. Guo).

(2014) Bo Kou et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

miR-145 downregulates the expression of cyclin-dependent kinase 6 in human cervical carcinoma cells

(2014) JING ZHANG et al.   Experimental and Therapeutic Medicine

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells

(2013) Ilenia Pellicciotta et al.   Cancer Cell International

Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival

(2013) Weimin Chen et al.   CELL CYCLE

A Novel Marine Drug, SZ-685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR-200c

(2013) C.-H. Chen et al.   CURRENT MEDICINAL CHEMISTRY

Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion

(2012) Thomas Cuny et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Translationally controlled tumour protein (TCTP) is a novel glucose-regulated protein that is important for survival of pancreatic beta cells

(2010) F. Diraison et al.   DIABETOLOGIA

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

(2010) Igor P. Pogribny et al.   INTERNATIONAL JOURNAL OF CANCER

BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists

(2010) Cintia M. dos Santos Silva et al.   Obesity

Acquired resistance to cabergoline: progression from initially responsive micro to macroprolactinoma

(2010) M. Alberiche Ruano et al.   Pituitary

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin

(2009) Guo-Qing Chen et al.   MEDICAL ONCOLOGY

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells

(2009) B Song et al.   ONCOGENE

Genes Differentially Expressed in Prolactinomas Responsive and Resistant to Dopamine Agonists

(2008) Vanessa Q. Passos et al.   NEUROENDOCRINOLOGY